Key market opportunities include identifying emerging trends and innovations, leveraging insights from recent mergers and acquisitions, optimizing supplier selection, staying informed about regulatory ...

The "Contract Pharmaceutical Manufacturing, Research, and Packaging Market Forecasts to 2029" report has been added to ResearchAndMarkets.com's offering. This report aims to provide in-depth knowledge ...

ProMed, a leading contract manufacturer specializing in medical-grade silicone and plastic components, provides comprehensive support for medical device, pharmaceutical, and combination drug-device ...

Sharp Sterile Manufacturing is investing $28 million to expand its site in Lee, Massachusetts, which offers a range of ...

What defined pharma in 2025? Contract Pharma’s most‑viewed breaking news offers insights. Here’s your yearly recap—the most ...

NEW YORK & MIAMI--(BUSINESS WIRE)--Aterian Investment Partners (“Aterian”), a private investment firm, is pleased to announce that one of its affiliates has entered into an agreement to recapitalize ...

SEOUL, South Korea, June 18, 2025 /PRNewswire/ -- LOTTE BIOLOGICS announced on June 19, 2025 that it has signed a contract manufacturing agreement for antibody therapeutics with Ottimo Pharma, a ...

HYDERABAD (Reuters) - Indian contract drug manufacturer Suven Pharmaceuticals said on Thursday it will merge with Cohance Lifesciences in an all-share deal, as it looks to further scale up its ...

From vitamin maker to pharmaceutical specialist and now contract manufacturer, India’s Lupin is embarking on a new phase of its corporate journey. Lupin on Monday unveiled its new subsidiary, Lupin ...

RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and ...

Global Pharmaceutical Manufacturing Equipment Market OverviewThe global pharmaceutical manufacturing equipment market is on a growth trajectory, projected to expand at a CAGR of 6–8% over the forecast ...

South Korea-based LOTTE BIOLOGICS signed a contract manufacturing agreement for antibody therapeutics with Ottimo Pharma, a biopharmaceutical company developing PD1/VEGFR2 dual pathway antibodies ...